SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-058601
Filing Date
2011-10-20
Accepted
2011-10-20 12:15:04
Documents
6
Period of Report
2011-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v237591_8k.htm 8-K 33328
2 EXHIBIT 10.1 v237591_ex10-1.htm EX-10.1 70879
3 EXHIBIT 10.2 v237591_ex10-2.htm EX-10.2 71989
4 EXHIBIT 10.3 v237591_ex10-3.htm EX-10.3 83411
5 EXHIBIT 10.4 v237591_ex10-4.htm EX-10.4 57344
6 EXHIBIT 10.5 v237591_ex10-5.htm EX-10.5 58014
  Complete submission text file 0001144204-11-058601.txt   376308
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 111149694
SIC: 4731 Arrangement of Transportation of Freight & Cargo